Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230672
Status:
COMPLETED
Last Update Posted:
2023-09-28
First Post:
2005-09-29
Brief Title:
Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs
Sponsor:
Imperial College London
Organization:
Imperial College London
Study Overview
Official Title:
Studies of Plasma Proteins Derived From Pulmonary Arteriovenous Malformation Patients
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hereditary Haemorrhagic Telangiectasia HHT also known as Osler-Weber-Rendu Syndrome is an disease that leads to the development of dilated and fragile blood vessels including arteriovenous malformations in the lungs PAVMs We hypothesize that the genetically-determined abnormality in the blood vessels of HHT patients leads to alteration in the concentrations or activity of several proteins in the blood stream We propose to take blood samples from patients at defined times in order to study changes in blood protein levels and activity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None